HCPCS code J1580: Gentamicin injection billing guide

Key takeaways

HCPCS code J1580 covers injectable gentamicin sulfate up to 80 mg per unit, billed as a Level II J-code under Medicare Part B.

Medicare pays J1580 on Average Sales Price (ASP) methodology, and the ASP file changes quarterly. Check the current rate before each billing cycle.

Medicare requires the 11-digit NDC on most Part B drug claims, and a missing or wrongly padded NDC is a leading denial trigger.

Practice management software like Pabau links drug administration records to billing codes in one workflow, so dose and NDC data reach the claim unchanged.

HCPCS code J1580 is the Level II code for billing injectable gentamicin sulfate. The official descriptor reads: Injection, garamycin, gentamicin, up to 80 mg. The Centers for Medicare and Medicaid Services, or CMS, publishes and updates the HCPCS code set.

Unlike CPT codes, which the AMA maintains, HCPCS Level II J-codes come from CMS and are updated annually. J1580 sits in the J1000-J8999 drug injection series. It applies to physician-administered gentamicin in outpatient and office settings.

Gentamicin (Garamycin) drug overview

Gentamicin sulfate is a broad-spectrum aminoglycoside antibiotic active against gram-negative organisms. Those include Pseudomonas aeruginosa, Escherichia coli, and Klebsiella species. Garamycin is the most widely recognized brand name. The drug is given parenterally, by intravenous infusion or intramuscular injection. Clinicians reserve it for serious bacterial infections where oral antibiotics fall short.

• Route of administration: IV infusion or IM injection
• Typical clinical uses: Septicemia, urinary tract infections, respiratory tract infections, skin and soft tissue infections, bone and joint infections, and endocarditis in combination regimens
• Monitoring requirement: Peak and trough serum levels are standard practice, because the drug has a narrow therapeutic index
• Setting: Mostly outpatient infusion centers, physician offices, and hospital outpatient departments

Gentamicin is physician-administered rather than self-administered, so Medicare Part B covers it under the buy-and-bill model. That applies when the drug is dispensed in an eligible outpatient setting.

How to bill gentamicin injections with J1580

Accurate gentamicin billing starts with the unit structure. One billing unit of J1580 covers up to 80 mg. A 160 mg dose bills two units, and a 240 mg dose bills three. Always round up to the next complete unit when the dose passes a multiple of 80 mg. The bands below show where each boundary falls.

Step-by-step billing checklist

1. Confirm the dose administered. Record the exact milligrams given in the clinical note. That note is the audit trail behind the units you bill.
2. Calculate units. Divide the dose by 80 mg and round up to the next whole number. A 120 mg dose bills as two units.
3. Select a supporting ICD-10 diagnosis. The claim needs a diagnosis code that establishes medical necessity. Vague diagnoses are a common denial trigger.
4. Record the National Drug Code (NDC). Medicare wants the 11-digit NDC, the N4 qualifier, the unit of measure, and the quantity administered.
5. Choose the place of service (POS) code. Use POS 11 for a physician office and POS 22 for an outpatient hospital. Rates differ by setting.
6. Pair with an administration CPT code. Infusion codes in the 96360-96379 range, or 96372 for a therapeutic injection, are billed alongside J1580. The right one depends on route, supervision level, and payer policy.
7. Submit a clean claim. Populate every required field before submission, so the claim does not come back for rework.

Commercial payer rules can differ from Medicare on modifier requirements, prior authorization, and covered diagnoses. Verify payer-specific policy before you submit.

Medicare reimbursement for HCPCS code J1580

Medicare Part B reimburses J1580 using Average Sales Price (ASP) methodology. In a physician office the payment rate equals ASP plus 6%. CMS refreshes ASP-based drug prices quarterly, so the allowable amount for J1580 changes four times a year. Never quote a fixed dollar amount without checking the current quarter’s CMS ASP file. Verify the rate in the CMS fee schedule lookup and the quarterly ASP drug pricing file.

Revenue cycle work on J-code drugs means tracking ASP movement quarterly and renegotiating commercial rates to match. Practices that set a drug rate once and forget it lose margin as ASP drifts. That risk is sharpest in IV therapy programs, where one drug drives most of the claim value.

Medicare coverage and medical necessity for J1580

Medicare Part B covers physician-administered injectable drugs that a patient cannot self-administer. Gentamicin meets that test, so it is eligible under buy-and-bill in an office or qualifying outpatient setting.

Strong medical billing compliance for J1580 comes down to one habit. Every claim links to a diagnosis that explains why the antibiotic was clinically necessary. Medicare Advantage plans may also impose prior authorization that traditional Medicare does not, so check the plan first.

ICD-10 diagnosis codes that support J1580

The ICD-10-CM codes below are commonly paired with J1580 claims. This list is not exhaustive, and coverage depends on Local Coverage Determinations (LCDs) and payer policy. Always pick the most specific code the documentation supports.

CMS publishes no universal LCD for J1580, so coverage falls to the Medicare Administrative Contractor (MAC) in your jurisdiction. Review your MAC’s LCD for injectable antibiotics to confirm the covered indications.

NDC crosswalk for J1580

The National Drug Code (NDC) crosswalk maps commercial gentamicin sulfate products to HCPCS code J1580. Medicare requires NDC data on drug claims filed on the CMS-1500 form or the electronic 837P transaction. Report the NDC in 11-digit format with the N4 qualifier, the unit of measure, and the quantity. Use ML for milliliters and UN for units.

Labelers print NDCs in three different segment layouts, and Medicare wants a single 11-digit string. Pad the short segment with a leading zero to reach the 5-4-2 pattern. A four-digit labeler code gains a zero. So does a three-digit product code, or a one-digit package code.

NDC assignments change when manufacturers alter packaging or labeling. Verify current NDC-to-HCPCS mapping against the FDA NDC Directory or the CMS NDC crosswalk file before you submit. An invalid NDC is a leading reason J1580 claims are rejected at the clearinghouse before adjudication.

Related HCPCS and CPT codes

Billing staff working with J1580 also need the administration codes and the unclassified-drug fallback. The table below covers the codes most often cross-referenced with J1580.

A frequent mistake is reaching for J3490 because the biller has not met J1580. Unclassified drug codes attract extra documentation requests and closer scrutiny. Use J1580 for gentamicin sulfate up to 80 mg per unit.

For programmatic lookup, the NLM Clinical Tables API offers free access to HCPCS Level II codes.

Common billing errors and denial reasons for J1580

Gentamicin claims fail in a predictable pattern, and most of it is fixable at submission. Six errors account for the bulk of J1580 rework.

• Missing or invalid NDC data. Medicare wants the 11-digit NDC, the N4 qualifier, the unit of measure, and the quantity on every drug claim. An absent or malformed NDC is rejected before adjudication. Denial codes for this error include CO-4 and CO-16.
• Unit miscalculation. Billing one unit for a 160 mg dose is the most frequent unit error. J1580 covers up to 80 mg per unit, so larger doses need more units.
• Non-specific or unsupported diagnosis. A diagnosis that does not establish medical necessity for injectable gentamicin draws a medical necessity denial. The ICD-10 code has to be specific and documented in the note.
• Wrong place of service. Rates differ between POS 11 and POS 22. Billing the wrong POS can underpay the claim or trigger a technical denial.
• Using J3490 instead of J1580. Gentamicin has its own J-code. Unclassified drug codes draw extra review and pay less when they pay at all.
• No administration code paired with the drug. J1580 covers the drug cost only. The injection or infusion service bills separately, so omitting it leaves earned revenue behind.

Weekly review of J-code denials clears them faster than a monthly batch. Steady denial management catches these six errors before they age into write-offs.

How Pabau supports J1580 billing workflows

The hard part of J1580 is that accurate billing depends on data captured during the clinical encounter. That means the exact dose, the NDC from the vial administered, and the supporting diagnosis. When clinical notes live in one system and billing in another, transcription errors follow.

Practice management software like Pabau connects the drug administration record to the billing workflow in one platform. The practitioner logs the drug, dose, and NDC at the point of care. The billing team opens that same record when preparing the claim, so nothing gets retyped.

Pabau’s claims management software sends the finished claim through our Claim.MD integration, which carries the NDC and unit fields the payer expects. For practices with recurring outpatient infusion patients, the reporting tools show claim acceptance rates and reimbursement trends over time.

Connect J-code billing to the clinical record

Pabau links drug administration records to billing codes in one platform, so dose and NDC data reach the claim unedited. See how it handles claims for physician-administered drugs.

Book a demo

Conclusion

The reimbursement figure is the part of J1580 that will not stay still. ASP moves every quarter, so any dollar amount you write down has a shelf life of three months. Build the quarterly check into your billing calendar and the rate stops being a surprise.

The rest of J1580 is unit math and an 11-digit string, and both are decided at the point of care rather than at submission. Capture the dose and the NDC while the vial is still in someone’s hand. Medical billing accuracy on drug codes depends on that timing.

To see how Pabau handles J1580 claims end to end, book a demo with our team.

Continue your research

Billing another Part B injectable this quarter? J1556 runs the same unit math and NDC reporting for immune globulin.

Collecting the coinsurance after Medicare pays its share? Patient payment plans shows how to stage the balance without chasing invoices.

Need the per-unit rules for a blood product instead? P9010 covers whole blood transfusion billing and the denials it attracts.

Frequently asked questions